Zymeworks Inc. (NYSE:ZYME) Given Average Rating of "Moderate Buy" by Analysts
Zymeworks Inc. (NYSE:ZYME – Get Rating) has received an average rating of “Hold” from the ten ratings firms that are currently covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month price objective among […]